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ABSTRACT
A representative sample of the Canadian public was interviewed to
determine their attitudes and perceptions of the risks and benefits
from prescription drugs. In general, prescription drugs, with the
exception of sleeping pills, antidepressants, and tranquilizers, were
perceived to be high in benefit and low in risk. They appeared to be
sharply differentiated from other chemicals and from illicit drugs.
Perceptions varied somewhat according to geographic region, age,
gender, education and tendency toward political activism on health
issues. Despite the general acceptance of drug risks, respondents were
very quick to call for withdrawal from the market of a drug suspected
of causing fatal reactions in some patients. Evidence for safety and
efficacy, in combination with warning information, appeared to make
these concerned individuals much more tolerant of the risks from such a
drug. Practical implications of these results and the need for further
research on risk/benefit perception are discussed.
Key words: perceived risk, perceived benefit, informed choice,
prescription drugs, attitudes, warning information,
patient information.
INTRODUCTION
Knowledge of risk perceptions has been demonstrated to be vitally
important in understanding how individuals and societies manage the
risks of daily life (1, 2). In medicine, perceptions of drug risks are
likely to influence patients' treatment choices, their compliance with
treatment regimens, their views on the acceptability of adverse
reactions and the drugs that cause them, and their attitudes toward
government regulation of drugs (3, 4). Understanding perceptions is a
prerequisite for designing better communication materials for patients
and the public.
To date, few studies have examined perceptions of the risks
associated with prescription drugs. The present study was designed to
meet the following objectives:
1. Describe precisely and quantitatively the Canadian public's
perceptions of risk and benefit from the use of various kinds of
prescription drugs.
2. Place perceptions of prescription drugs within a broader
context of perceptions regarding many other activities (e.g.,
driving, smoking) and technologies (e.g., air travel, pesticides),
including other medical technologies (X-rays, surgery).
3. Allow comparisons to be made across important personal and
demographic characteristics (e.g., health status, age).
4. Provide baseline data that will allow the impact of new drug
problems and controversies to be monitored and allow trends in relevant
attitudes and perceptions to be followed over time.
5. Help pharmaceutical companies understand the influence of
public perceptions on the sociopolitical environment in which they
operate.
A prior study of this type examined the attitudes and perceptions
of a representative sample of the general public in Sweden (5). This
paper reports the results of a comparable study, based upon a national
survey in Canada.
DESIGN AND ADMINISTRATION OF THE SURVEY
The Canadian survey followed the basic design of the Swedish
survey, with only a few modifications. The survey had three main
components, as described below. The full questionnaire is available
from the authors.
Part I: General Attitudinal and Demographic Questionnaire
Part I of the survey employed a traditional format in which
respondents were asked to indicate their attitudes, perceptions, and
opinions in response to specific questions. These questions dealt with
topics such as:
• Perceptions of risk today as compared to risks in the past
• The nature and perceived frequency of drug side effects
• The adequacy of performance by government regulators, drug
manufacturers, physicians, and pharmacists in ensuring drug
safety and efficacy
• The respondent's personal experiences with drug side effects
• Perceived causes of drug side effects
• Opinions in response to a scenario describing a drug crisis
• Attitudes toward receiving precaution and warning information
about a drug.
In addition, Part I included a non-traditional task in which
respondents were asked to read the words 'prescription drugs' which
were printed six times on a card. Each time they read these words,
they were instructed to write down the first association that came to
their minds. Of particular interest in this task is the frequency and
nature of positive and negative associations to prescription drugs.
Part II: Risk/Benefit Perceptions
Each of 33 items was rated by each respondent on a scale of risk
and a scale of benefit. The 33 items included 19 pharmaceutical
products (e.g., vaccines, antibiotics), 5 medical devices or procedures
(e.g., X-rays, heart surgery), and 9 non-medical items (e.g.,
automobiles, nuclear power plants). 'The pharmaceutical items were
carefully selected according to several criteria, including importance,
familiarity to the general public, and diversity. The non-medical
items were included to provide a broad context against which to compare
the medical and pharmaceutical items.
The risk scale asked: "To what extent would you say that people
who are exposed to this item are at risk of experiencing personal harm
from it?" The rating scale went from 1 (they are not at risk) to 7
(they are very much at risk). The benefit scale asked: "In general,
how beneficial do you consider this item to be for society as a whole?"
(1 = not at all beneficial; 7 = very beneficial). All 33 hazard items
were rated on one scale before the other scale was considered. Before
starting this task, respondents were asked to examine a glossary which
defined each term (e.g., insulin--a drug used to treat diabetes).
Respondents were allowed to refer back to this glossary as necessary
during this task.
Part III: Personal Information about Respondents
The third section of the survey elicited information pertaining to
the general attitudes and personal background of the respondent. This
section included questions pertaining to the patient's age, sex,
education, region of residence, native language, health status,
cigarette smoking, occupation, income, marital status, medicine usage,
interest in news items on health and medicine, health consciousness,
attitudes toward risk taking, attitudes toward fate, and attitudes
toward using medicines. It also included a question asking about
actions that the respondent would be likely to take in the event of an
important health decision facing the government. These actions ranged
from acquiring information or signing a petition to joining a consumer
group that is involved in the issue. Answers to these attitudinal and
background questions were examined to determine whether any of these
factors were associated with perceptions and attitudes pertaining to
drug risks.
Administration of the Survey
A representative sample of the Canadian adult population was
interviewed in person in their own homes by personnel from Gallup
Canada. The interviews took place between February 8 and February 20,
1989. From 2874 eligible persons contacted, 1261 completed interviews
were obtained, for a completion rate of 44%. Quota sampling was done
to insure proper representation of males and females, regions of
residence, community types, and community sizes. The sampling frame
was identical to that typically used by Gallup Canada in political
polling that has been found to be quite accurate in forecasting
election results.
RESULTS
Characteristics of the Sample
The sample was about equally split between females (49.4%) and
males (50.6%). About 9.5% of the respondents came from the Atlantic
provinces1, 25.7% from Quebec, 36.2% from Ontario, 17.1% from the
prairie provinces2, and 11.4% from British Columbia. The mother tongue
was English for 62.4% of the respondents, French for 25.3%, and neither
English nor French for 12.3%. The mother tongue was French for 87.0%
of those residing in Quebec. Some 20.2% of the respondents were
between the ages of 18 and 29; 25.1% were between the ages of 30 and
39; 16.7% were 40-49; 21.0% were 50-64; and 16.7% were 65 years of age
or older.
Education levels were diverse; 11.9% had a public (elementary)
school education or less, 48.1% had attended high school (about 60% of
these people had graduated), 17.4% had at least some university
education, 17.5% had attended a community college, and 5.0% had at
least some graduate school training. Occupational backgrounds were
evenly distributed across professional, technical, business, sales,
homemaker, clerical, and skilled and unskilled labor.
The majority of respondents rated their health as either excellent
(21.7%) or very good (52.5%). Not surprisingly, a smaller proportion
1 The Atlantic provinces include New Brunswick, Nova Scotia,
Newfoundland, and Prince Edward Island.
2 The prairie provinces include Manitoba, Saskatchewan, and Alberta.
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(60.1%) of people older than 65 years rated their health in these two
highest categories. People with University and Graduate educations
rated their health as much better (88.2% excellent or very good for
University; 88.9% for graduate education) than did people with only a
public school education (55.3% excellent or very good). Income and
occupation was also positively correlated with health status. Self-
rated health status was lowest for those who gave their occupation as
homemaker and was highest for professionals, persons in sales or
clerical jobs, and students.
About one-fifth (20.8%) of the respondents reported seeing their
physicians regularly. Heart, blood pressure, arthritis, and back
problems were listed as the major reasons for consulting a physician.
Some 35.0% of the sample said that they were currently taking some kind
of medication (either prescription or non-prescription). When asked to
describe that medication, drugs to treat high blood pressure, pain
relievers, heart medicines, tranquilizers, and arthritis drugs were
among those most commonly mentioned. Current use of medicines was
highest in the Atlantic region (40.8%), lowest in Quebec (28.1%),
highest among those 65 years of age or more (63.0%), higher for women
(42.2%) than for men (27.8%), and inversely related to education and
income.
When asked whether they had significantly benefited from taking a
prescription drug in the last 5 years, 54.2% replied that they had.
Those residing in Quebec were less likely to reply in the affirmative
(42.9%) than were those living in British Columbia (76.4%) or the
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Atlantic region (66.7%). The proportion of persons reporting benefits
was higher among older people (66.4% in ages 65+), women (59.1%),
housewives (61.2%), and health-care workers (64.3%). The categories of
benefits reported were improvement in chronic conditions (39.5%), cures
(25.7%), symptom relief in temporary illness (24.1%), pain relief
(18.7%), and the saving of life (5.0%). Cures were reported much more
frequently by the respondents between the ages of 18 and 29 (44.5%)
than by those 65 years of age or older (12.1%). Improvements in
chronic conditions were reported frequently among the oldest
respondents (67.9%) as was the saving of life (12.1%).
When asked to rate the degree of attention they paid to news items
about health and medicine on a five-point scale (1 = very little; 5 =
very much), the mean response was 3.64, and most respondents rated
their attention level as 3 (25.3%), 4 (31.1%) or 5 (27.8%). The
highest ratings were obtained in Quebec (37.0% in Category 4 and 32.4%
in Category 5). Women had higher ratings than men (35.2% in category 5
as compared to 20.5% for men). Health-care workers stood out with a
mean rating of 4.15 (48.8% rated their attention level as 5). No other
subgroup differences were marked.
When asked whether or not they were aware of any recent news items
about prescription drug problems, 28.4% said that they were. These
individuals were asked to indicate the content of those items. The
most frequent responses were Thalidomide babies (27.1%), AIDS treatment
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(12.8%), Halcion sleeping pills (10.9%), controversies over birth
control (7.8%), and generic drug issues (4.7%).
Respondents were also asked to indicate the degree to which
various statements about risk taking, health consciousness, fatalism,
and medicine taking described them personally. Most of these
individuals (67%) said that they were "very" or "somewhat" well
described as not liking to take risks and being health conscious
(93.4%). Only 46.8% said they were very well or somewhat well
described as feeling comfortable about taking medicines whenever they
did not feel well. There was also divergence of views regarding fate.
About 40.6% said they were very well or somewhat well described by the
statement that they believed most mishaps in life are predetermined by
fate and unavoidable; 56.9% said that such beliefs described their
personal views very poorly or not at all.
' There were several subgroup differences in responses to the
statement that "I feel comfortable taking medicines whenever I don't
feel my best." Only 9.9% of those residing in Quebec responded that
this described them very well (compared with 16.0% in the total
sample). Some 50.0% of those in Quebec said this described them very
poorly (as compared with 10.0% for those in the Atlantic region).
People aged 65 or older reported being more comfortable taking
medicines than did younger people.
Images of Prescription Drugs
More than 3000 associations were produced in response to the
stimulus concept 'prescription drugs.' The major types of associations
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are listed in Table 1 in order of their frequency. The term "doctor"
headed the list, followed by associations to pharmacies and concerns
about costs. Strong positive images (necessary, beneficial) accounted
for 179 responses. Strong negative images were more frequent and took
three general forms: one had to do with safety concerns (122
responses); the second had to do with overuse, abuse, addictiveness,
and dependency (173 responses); the third had to do with lack of
necessity or worth (33 responses). Of interest is the fact that there
was very little association of prescription drugs with illicit drugs
and few references to natural or herbal medicines. Overall, these data
in Table 1 provide a baseline against which to compare responses over
time in Canada and responses from other nations.
Insert Table 1 about here
Present and Past Risk
Respondents were asked to indicate whether they believed that
there is more risk, less risk, or about the same risk today than there
was 20 years ago for each of several types of hazards. The results,
shown in Figure 1, indicate that the risks from chemicals were
perceived to be greater today by 83.7% of the respondents. Other
percentages for the 'more risk' response were heart disease (70.7%),
cancer (74.0%), food (69.2%), quality of drinking water (61.9%),
methods of travel (61.4%), climate changes (57.3%), energy sources
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(54.2%), infectious diseases excluding AIDS (42.3%), and prescription
drugs (37.7%). Looking at the other side of the coin, the proportion
of responses in the 'less risk today' category was highest for
infectious diseases (37.4%) and prescription drugs (32.7%) and lowest
for chemicals (16.3%) and climate changes (7.8%).
Insert Figure 1 about here
We thus see a strong difference between the perceived trend in
risk for prescription drugs and the perceived trends for chemicals as a
whole and for other technologies. Although about one-third of the
sample believes that drug risks have increased during the past 20
years, this is far smaller than the percentage perceiving increased
risk from the other hazards, with the exception of infectious disease
(which may be seen as closely linked to drug efficacy).
Drug Efficacy and Side Effects
Several questions asked about drug efficacy and the frequency,
severity, and causes of side effects. When asked to rate the job that
various health-care agents were doing to make sure that prescription
drugs are safe and effective, pharmacists received the highest marks
(75.6% excellent or good), followed at quite a distance by doctors
(57.3%), government regulatory agencies (44.9%) and drug manufacturers
(40.0%).
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When asked how often "the drug works as it should for patients
taking prescription drugs", 72.8% replied always, very often, or often;
18.5% replied occasionally, and 3.9% said rarely or never. When asked
how often patients taking prescription drugs experience unwanted
effects/side effects, 28.8% replied always, very often, or often; 19.8%
replied rarely or never. Asked to specify the most serious side
effects/unwanted effects that occur with use of prescription drugs, the
combination of nausea, stomach irritation, or vomiting was mentioned by
25.5% of the respondents, dizziness or drowsiness by 20.7%, allergic
reactions by 18.0%, addiction by 12.8%, rash by 9.3%, mental problems
(including disorientation, forgetfulness, and hallucinations) by 8.0%,
headaches by 7.2%, death by 6.2%, and heart and circulatory problems by
5.2%.
When asked whether they personally had suffered a side effect or
unwanted effect from taking a prescription drug during the past five
years 27.5% of the sample replied that they had (see Figure 4); of
these people, 32.6% considered the side effect to have been severe. A
similar proportion (32.6%) rated their personally experienced side
effect as having been mild and 34.3% rated it as moderate in severity.
Asked to describe the kind of side effect/unwanted effect they had
suffered, the predominant responses included nausea, stomach
irritation, vomiting, drowsiness, rash, headaches, and mental effects
(forgetfulness, disorientation, hallucinations).
Respondents were also asked to indicate their opinions about the
main cause of a drug side effect. Their spontaneous responses, shown
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in Table 2, named patient sensitivity or incompatibility, improper drug
prescription, incorrect examination by the doctor, and misuse by
patients as the major causes. Following this question was a structured
question that asked people to indicate how frequently each of eight
specified factors is the cause of a side effect. The results indicated
that failure of the patient to follow instructions was judged the most
likely cause (55.5% rated it always, very often or often a cause),
followed closely by failure to give the patient enough information
(52.2% rated it always, very often, or often a cause). Patient
sensitivity was again singled out as one of the most frequent causal
factors (44.5% always, very often, or often), followed by improper
monitoring of the patient by the doctor (33.7% always, very often, or
often). Less frequent attributions of causality were assigned to
inadequate testing by the drug manufacturer (21.1%), wrong prescription
(16.7%), or wrong dosage prescribed (15.6%). Pharmacist's mistakes
were seen as the least likely cause of a drug-induced side effect (1.9%
always, very often, or often).
Insert Table 2 about here
A Drug Crisis Scenario
The following hypothetical scenario was posed to each respondent,
indicating a possible link between a drug and some fatalities among its
users.
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'Imagine that a new prescription drug becomes available
in this country for treating a serious disease. Other drugs
are also available for treating this disease. A study
reveals that some people may have died from taking this drug.
What do you think the government should do in this case?'
-- Leave the drug on the market.
-- Take the drug off the market.
-- Leave the drug on the market but warn the doctors
and patients.
- - Not sure.
In response to this scenario, 60.1% of the respondents wanted the
government to take the drug off the market, 3.3% wanted the drug left
on the market, 35.1% wanted it left on the market with a warning, and
1.4% were not sure what should be done.
Insert Figure 2 about here
Those who wanted the drug removed from the market or who were not
sure (61.5% of the total sample) were asked to reconsider their
answers, taking into account each of six possible extenuating
circumstances. The results, shown in Figure 2, indicated that there is
no circumstance that, by itself, would convince more than about 25% of
these people to leave the drug on the market as it was before.
However, in combination with information warning physicians and
patients about the possible problem, these additional considerations
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led to substantial changes in opinions. Knowledge that the risk
affected only "certain types of patients, such as elderly persons with
liver problems" convinced 4.3% of these respondents to leave the drug
on the market and another 62.1% to leave it on the market with a
warning. Changes such as this also occurred when respondents were told
that the drug is more effective than other, similar drugs, or that the
drug has fewer side effects for most patients than other, similar
drugs. Being told that the drug has been used safely and effectively
for many years in another country or that you've taken the drug for
many months and are very satisfied with it produced somewhat less
change of opinions. The circumstance that produced the least opinion
change was the fact that the government and manufacturer are actively
gathering more information about the problem.
Attitudes Toward Warning Information
There have been numerous surveys indicating that patients strongly
desire warning information pertaining to prescription drugs (see, e.g.,
6, 7, 8). When the drug-crisis scenario described above was evaluated
in the Swedish survey, the results suggested that use of warning
information could greatly affect the acceptability of a risky drug (5).
When that vignette was repeated in the present survey, the results
confirmed the Swedish findings (see Figure 2). Because of the
importance of this issue, the present survey included several questions
pertaining to warnings that had not been included in the Swedish
survey.
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One question began with the statement "Information describing the
precautions and side effects/unwanted effects associated with taking
prescription drugs would ..." This statement was followed by seven
different endings and, for each, the respondent was asked to indicate
degree of agreement or disagreement. The results are shown in Figure
3. There was overwhelming agreement with the statement that
precautions and warning information "would help me to recognize and
avoid problems when taking the drug" (92.5% agreed or strongly agreed).
Respondents also believed that such information would encourage them "to
"to take the drug exactly as prescribed" (90.1% agreed or strongly
agreed). They also believed that this type of information "ought to
describe all possible side effects, even if some of them are extremely
unlikely" (85.6% agreement) and correspondingly tended to disagree with
the statement that "only the most likely side effects" ought to be
included (40.0% agreement; 56.5% disagreement). In addition, 64.8% of
the respondents agreed or strongly agreed that such information
"indicates that the drug may be too dangerous to use," 53.9% agreed
that it would "make me uneasy about taking the drug," and 47.5% agreed
that such information "is generally hard to understand."
Insert Figure 3 about here
Two additional questions probed further into attitudes toward
warnings. The first was based on a study of perceptions of the risks
from household chemicals (cleansers, bleaches, etc.) conducted in the
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United States by Kraus and Slovic (9). That study found that 59% of
the respondents agreed and 22% strongly agreed with the statement "I
feel safer when I use a (household) product that has caution/warning
information on the label than I do when I use a similar product that
does not have caution/warning information on the label." This question
was asked in the present survey with the words "prescription drug"
substituted for the words "household product." Because prescription
drugs are associated at times with serious side effects, we expected
that many respondents might disagree with this statement. This did not
occur: 42.6% strongly agreed and another 50.0% agreed that warning
information made them feel safer. Only 3.3% disagreed and 2.1%
strongly disagreed with this statement.
The second question was designed to assess attitudes toward the
strategy of marketing a drug or medical product to a targeted patient
population coupled with extensive warnings about the risks. This
strategy is currently being pursued by Alza Corporation in their
marketing of the IUD, Progestasert (10) and by Hoffman-LaRoche, Inc. in
their marketing of the anti-acne drug Accutane. The question asks for
degree of agreement or disagreement with the statement "When drugs have
a potential for serious unwanted effects/side effects, patients should
be required to read warning information and to sign a form indicating
that they understand the risk before being allowed to take the drug."
Again there was substantial agreement with this strategy. Some 43.4%
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of the respondents agreed and 33.7% strongly agreed with the statement,
15.8% disagreed, and 4.7% strongly disagreed.
Perceived Risks and Benefits
Ratings of each hazard item were averaged across all 1261
respondents for both the risk and benefit scales in Part II of the
survey. The mean ratings for perceived risk, ordered from high to low,
are shown in Figure 4. Three non-drug chemicals--cigarette smoking,
pesticides, and alcohol--stood out (with nuclear power) as highest in
perceived risk, followed closely by three drug items--sleeping pills,
tranquilizers, and antidepressants. Vitamin pills, herbal medicines,
vaccines, and acupuncture were judged lowest in risk. Prescription
drugs in general and most specific drugs (e.g., antibiotics, anti-
arthritics) were judged to have only low or moderate degrees of risk.
Insert Figure 4 about here
The prior survey in Sweden found that high perceived risk for
sleeping pills and antidepressant drugs was associated with images of
addiction, abuse, dependency, and overuse. To test this relationship
in the present study, the responses of 294 persons who mentioned one of
these problems on the image question or on the question regarding the
most serious side effects from prescription drugs or on both of these
questions were compared with 964 persons who never once mentioned
addiction, abuse, etc. in those questions. The results, shown in
Table 3 for the nine statistically significant items, again indicate
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the link between addiction, abuse, dependency, and overdose and higher
perceived risks for antidepressant drugs and sleeping pills.
Tranquilizers and arthritis drugs also exhibited this link to a
relatively great extent.
Insert Table 3 about here
Mean ratings of perceived benefit are shown in Figure 5. High
benefits were associated with automobiles and air travel as well as
pharmaceutical products such as insulin, antibiotics, vaccines, cancer
drugs, and prescription drugs in general. Heart surgery and x-rays
also fell in the highest range of perceived benefit. Very low benefits
were attributed to smoking cigarettes and drinking alcoholic beverages
as well as to non-drug chemicals such as food additives, artificial
sweeteners, and pesticides.
Insert Figure 5 about here
The risk and benefit means are superimposed in Figure 6.
Perceived risks and benefits were related in a negative way (their
correlation across items was -.46). Vaccines, insulin, appendectomy,
and prescription drugs as a whole stood out as being quite high in
perceived benefit and low in perceived risk. Other drug items, with
the notable exception of sleeping pills, tranquilizers, and
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antidepressants, showed a similar, though less extreme, pattern. Three
non-drug chemical hazards--cigarettes, alcohol, and pesticides, along
with nuclear power, were judged extremely high in risk and low in
benefit.
Insert Figure 6 about here
Subgroup Differences: Part I
There were numerous differences between subgroups of the sample
for the questions in Part I of the survey. Although these differences
were often sizable, they rarely led to any reversal in the main trends
that appeared in the overall sample.
Regional differences. Respondents in the Atlantic provinces and
in Quebec consistently stood apart from each other and from the other
respondents in their attitudes and perceptions. Atlantic respondents
tended to be the most positively oriented toward prescription drugs and
those in Quebec were least positive. Specifically, Atlantic
respondents were most likely to say that:
• there is less risk from prescription drugs today than 20 years
ago
• prescription drugs always or very often work as they should
• government agencies, drug manufacturers, doctors, and
pharmacists do a good or excellent job of ensuring drug safety
and efficacy
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• patient misuse of drugs is an important cause of side effects.
Atlantic respondents were least likely to say that patients always
or very often experience side effects. One exception to their
generally favorable attitudes toward prescription drugs were their
responses to the second part of the drug-crisis scenario. There,
Atlantic residents were least likely to say that the drug in question
should simply be left on the market in the light of information about
its safety and effectiveness.
As noted earlier, Atlantic residents also had the highest
proportion of respondents currently using prescription drugs, the
highest proportion claiming not to be risk takers, and the highest
proportion indicating that they feel comfortable taking medicines.
Respondents from Quebec tended to be at the other extreme from the
Atlantic respondents. In addition to being least likely to say they
were comfortable taking medicines, they were most likely to say that:
• drug risks are higher today than 20 years ago
• patients often experience side effects
• the side effects they personally experienced were severe
• they personally experienced nausea or stomach irritation as side
effects.
• they pay close attention to news about prescription drug
problems.
On the other hand, residents of Quebec were the most likely to say
that the drug in question in the crisis scenario should be left on the
market given evidence in favor of its safety and efficacy.
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In the risk/benefit rating section of the survey, Atlantic and
Quebec respondents did not differ much in their ratings of the
perceived risk of the various pharmaceutical items. However, Atlantic
residents had higher perceptions of benefit for 25 of the 33 items. A
noticeable exception to this trend occurred with herbal medicines,
which received higher ratings of benefit by residents of Quebec. Payer
(11), in her book Medicine and Culture, discusses the preference for
"gentler medicines" in France. The present data indicate that a
similar preference exists in Quebec.
Age. Many age differences were observed. In general, the older
respondents were more likely to associate "costs," "benefits," and
"overdose" with the term "prescription drug." They were also more
likely to say that:
• the side effects they had personally suffered were severe
• a drug that they had taken successfully should be left on the
market (in the crisis scenario)
• a drug that only harmed specific types of patients such as
elderly persons with liver problems should be taken off the
market
• precaution/warning information would make them feel uneasy about
taking the drug.
Older people were less likely to say that:
• the most serious side effects include death and addiction
• frequent causes of side effects are incorrect dosage, patient
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sensitivity, patient misuse, improper monitoring by the doctor,
or problems with the drug itself.
Sex. Women had generally less favorable attitudes and perceptions
regarding the risks and benefits of prescription drugs. They were more
likely than men to associate safety concerns with the term
"prescription drug." They were also more likely to say that:
• patients always or often experience side effects
• they themselves had experienced side effects during the past 5
years
• the side effects they had experienced were severe
• they had experienced rashes and allergies as side effects
• inadequate patient information is a major cause of side effects
• the drug in the crisis vignette should be taken off the market
• warning information would make them feel uneasy about taking the
drug.
On the positive side, women were more likely than men to say that
a prescription drug always or often works as it should.
Education. There were many large differences in perceptions and
attitudes that were associated with educational background. Overall,
persons having more extensive formal education tended to have more
favorable attitudes and perceptions regarding the risks and benefits
from prescription drugs. Specifically, in comparison with persons
having high school educations or less, those with university and post
graduate educational experience were more likely to say that:
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• a prescription drug always or very often works as it should
• serious side effects include death
• the government is doing a good or excellent job in ensuring drug
safety and efficacy
• important causes of side effects are inadequate information for
patients and failure of patients to follow instructions.
Persons with more extensive educational backgrounds were less
likely to say that:
• there is more risk today from drugs and chemicals than there was
20 years ago
• persons taking prescription drugs always or very often
experience side effects
• the side effects they had personally experienced during the past
five years were severe
• inadequate government regulation was a frequent cause of side
effects
• the drug under suspicion in the crisis scenario should be left
on the market (without special warnings) in light of evidence
pertaining to its safety and efficacy
• warning information should include only the most likely side
effects.
Activism. A series of five questions asked respondents to
indicate on a 1-7 scale how likely they were to do each of five actions
in the event of a major health decision facing Canada. The actions
were a) seek more information, b) sign a petition, c) alert others, d)
28
write a letter, and e) join a consumer group. An activism score was
obtained by summing an individual's ratings over the five questions.
The scores ranged from 5 to 35 with a mean of 23.4 and standard
deviation of 7.1. The distribution of scores was divided into three
segments of approximately equal numbers of respondents. There were 428
persons (34.2% of total) with scores of 20 or lower. These individuals
were labeled non-activists. The 390 individuals (31.2%) with the
highest scores (28 or higher) were labeled activists. The activist and
non-activist groups were compared on the other survey questions. The
middle 34% of the distribution was not examined further.
Activists were found to differ from non-activists in many ways.
Particularly striking was the fact that a higher percentage of
activists reported having suffered a drug side effect (32.8% to 22.4%)
and, of those with side-effect experience, 41.4% were reported to be
severe by activists versus only 26.0% severe effects for non-activists.
There was no difference in the percentage of individuals within each
group who had reported benefiting from a prescription drug.
Activists were more likely to say that they were "very well
described" as being health conscious (58.7% vs. 35.5%), fatalists
(17.4% vs. 9.8%; this seems surprising); and non-risk takers (35.6% vs.
27.1%).
Activists were more likely to say that prescription drugs often,
very often, or always cause a patient to experience side effects (34.3%
vs. 25.8%). They were also more likely than non-activists to attribute
29
side effects to lack of testing by the manufacturer, inadequate
government regulation, and incorrect prescription of drug or dosage by
the doctor. Activists were less likely to attribute side effects to
patient sensitivity to the drug.
There was little difference between activism groups with respect
to initial response to the drug-crisis scenario. However, on the
follow-up questions given to those who initially wanted the drug
removed from the market, activists were consistently more likely to
agree to leave the drug on the market given that it was accompanied by
warning information. For example, if the drug was said to have fewer
side effects, overall, than similar drugs, 56.2% of the activists would
leave it on the market with a warning compared with 41.9% in the non-
activist group (the percentages who would leave it on the market with
no warning were about equal for both groups).
In response to specific questions about warnings and precautions,
activists were consistently more favorable towards disclosure of risk
information. Specifically, activists were more likely to strongly
agree that warnings and precautions would encourage them to take the
drug exactly as prescribed (37.2% vs. 30.4%) and should include all
side effects (42.5% vs. 35.5%). However, activists were also more
likely to agree and strongly agree that such information would make
them uneasy about taking the drug (58.5% vs. 50.5%).
Activists were also more likely to strongly agree that they feel
safer taking a drug that has warnings and precautions (56.2% vs.
45.8%). The largest difference between the two groups occurred with the
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statement that patients should be required to read warning information
and sign a statement of understanding before being allowed to take the
drug; 40.5% of the activists strongly agreed with this proposal as
compared to 28.3% of the non-activists.
Subgroup Differences: Part II
Regional differences were again apparent in looking at the
quantitative risk and benefit ratings in Part II of the survey.
Residents of the Atlantic provinces gave slightly higher ratings of
perceived risk to the general category "prescription drugs" than did
residents of the other provinces and residents of Quebec gave the
lowest risk ratings to prescription drugs, in keeping with their
responses to questions in Part I of the survey. However, differences
between Atlantic residents and those in Quebec were particularly high
with regard to rated benefits of prescription drugs. Atlantic
residents had a mean benefit rating of 6.07 (57.5% in category 7)
compared with a mean of 5.44 for residents of Quebec (31.2% in category
7). Other regions had intermediate benefit ratings. Atlantic
residents also stood out as having the highest mean benefit ratings for
non-prescription drugs.
Women had perceptions of risk that were equal to or greater than
the perceptions of men for every one of the 33 items. The largest
differences were found with nuclear power, alcohol, antibiotics,
sleeping pills, tranquilizers, IUDs, air travel, laxatives, and
aspirin.
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Fewer sex differences were obtained with perceived benefit.
However, women did perceive significantly greater benefit from birth
control pills and significantly less benefit from nuclear power plants,
pesticides, IUDs, food additives, and alcohol.
Activists consistently exhibited higher perceived risk than non-
activists, particularly for food additives, IUDs, alcohol, birth
control pills, sleeping pills, aspirin, and tranquilizers. There were
no differences for AIDs drugs, vaccines, heart surgery, or
appendectomy. Activists also rated perceived benefit higher than non-
activists for five items--herbal medicines, vitamin pills,
appendectomy, cancer drugs, and anti-hypertensive drugs. The two
groups' perceptions of benefit did not differ significantly on the
remaining items. In general, activists and non-activists differed more
in tft'eir perceptions of risks than in their perceptions of benefits.
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DISCUSSION
The broad pattern of results from this survey is very consistent
with the results from the national survey in Sweden. In both Sweden
and Canada, two main results were clearly evident.
• Prescription drugs were perceived to be high in benefit and low
in risk. They appeared to be sharply differentiated from other
chemicals and from illicit drugs. The only exceptions to this
favorable pattern of perceptions occurred with sleeping pills,
antidepressants, and tranquilizers (note that tranquilizers were
studied only in Canada). It is also significant, we believe, that
causes for side effects tended to be attributed more to patient
sensitivity or actions by the physician than to improper
manufacturing, testing, or regulation of the drug.
• Despite the general acceptance of drug risks, people were very
quick to call for withdrawal from the market of a drug
suspected of causing fatal reactions in some patients.
Evidence for safety and efficacy, in combination with warning
information, appeared to make these concerned individuals much
more tolerant of the risks from such a drug.
This second major finding was extended in the present survey by
the addition of several new questions pertaining to precautions and
warning information. Canadian respondents strongly endorsed the
provision of warning information, saying that it would encourage them
to use the drug exactly as prescribed, that it would help them to
recognize and avoid problems, that it made them feel safer, and that it
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ought to include all side effects, not only the most likely ones. For
drugs with the potential for serious side effects, respondents wanted
patients to be required to read the warnings and sign a form indicating
that they understood the risk before being allowed to take the drug.
Carpenter (10) has argued that the provision of extensive, frank
warnings and precautions is desirable because it affords the patient
the opportunity for "informed choice." The concept of informed choice
is a powerful idea with the potential to revolutionize the role of risk
and warning information in the marketing and use of prescription drugs.
The concept is currently being implemented in conjunction with several
high-risk products and the success or failure of these ventures will be
very informative. However, additional information will be needed to
delineate the boundaries for the successful application of this
approach. For which types of pharmaceutical or medical products will
it be favorably received? Under what circumstances would such an
approach be ill advised? The present study uncovered some potentially
adverse responses to warnings in the form of uneasiness about taking
drugs and concerns that the drug may be too dangerous to use. Would
such concerns deter some patients from taking essential medicines?
Would they lead to non-compliance with the prescription regime? We
believe that new studies, focused specifically on issues raised by the
concept of informed choice, are important to pursue.
Although the surveys in Sweden and Canada produced remarkably
similar overall results, close examination of their findings uncovers
many interesting differences.
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One such difference is that the subgroup differences in Sweden
were infrequent and small. In Canada they were frequent and sizable.
Residents of the Atlantic region were generally the most favorable in
their view of the risks and benefits of prescription drugs and
residents of Quebec were generally least favorable. In view of the
fact that residents of these regions did not differ significantly on
any background or demographic variables except "mother tongue," these
differences appear to be cultural in origin. Another subgroup effect
was the fact that older respondents had substantially different views
than did younger persons. Differences in educational background and
gender were also associated with different attitudes and perceptions.
Further efforts should be made to verify and understand the causes of
these subgroup differences, which could be important in designing and
marketing drug products and communicating with patients.
One important subgroup, activists, was studied in Canada but not
Sweden. Canadian activists appeared to be persons who have been
sensitized to drug risks through personal experience with side effects.
They tended to blame government, manufacturers, and physicians for side
effects, rather than patients, and they strongly favored the provision
of warning and precaution information to patients.
One particularly large difference between Sweden and Canada
occurred in the response to the word-association task. In Canada,
"Costs" were the third most frequent category of responses to the
stimulus term "prescription drug"; in Sweden, costs were infrequently
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given as an association (they ranked 18th in frequency with 33
mentions). This should not be surprising given the different methods
of financing health care in the two countries, but it does serve to
demonstrate the sensitivity of the word-association method to
differences in concerns.
In sum, the risk-perception surveys in Sweden and Canada have
provided insight into fundamental attitudes and perceptions regarding
prescription drugs. Further replication of these studies in other
countries and with patient subgroups as well as with the general public
should help pharmaceutical companies better understand patients'
concerns, meet their needs for information, and facilitate wiser and
safer use of prescription drugs.
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Table 1
Associations to "Prescription Drugs"
Rank Association Count Percent
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Doctor
Drugstore/Pharmacy
Cost/Expense Concerns
Drug/Pill/Medicine--Specifieda
Drug/Pill/Medicine--Unspecified
Illness/Sickness
Necessary/Beneficial
Hospital
Safety Concerns0
Medical Coverage/Health Insurance
Overuse
Tylenol
Abuse
Addictiveness/Dependency
Health
Family, Children, Baby
Need for More Information on Drugs
Unnecessary/Unworthwhi1e
Paraphernalia--bottles, needles, etc
Generic
Profit
Death
Warning
696 55.2
471 37.4
403 32.0
389 30.8
345 27.4
328 26.0
179 14.2
128 10.2
122 9.7
109 8.6
67 5.3
66 5.2
53 4.2
53 4.2
49 3.9
42 3.3
35 2.8
33 2.6
25 2.0
24 1.9
10 0.8
6 0.5
0.4
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a e.g., antibiotics, penicillin, Valium, insulin
b also includes helpful, recovery, reliable
c also includes dangerous, some risk, trouble, handle with care
Table 2
Reasons for Side Effects: Spontaneous Mentions
Chemical Incompatibility with Patient
Patient Allergic
Insufficient/Incorrect Examination by Doctor
Wrong Prescription
Wrong Strength/Dosage
Misuse by Patient
Not Enough Known About Drug
Problems with Drug Itself
Drug Interaction with Other Substance
Overuse/Overdose
Patient Given Wrong/Inadequate Information
No Answer/Don't Know
Frequency
19.7%
19.7%
15.5%
13.6%
13.3%
12.8%
7.6%
7.5%
5.7%
5.4%
3.9%
4.7%
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Table 3
Effects of Concerns about Addiction, Dependency,
Abuse or Overuse on Mean Perceived Risk
Respondent Subgroup
40
not concerned concerned
(N = 964) (N - 294) t
Antidepressants 4.64 5.04 3.88
Tranquilizers 4.80 5.15 3.49
Sleeping Pills 4.91 5.24 3.33
Antiarthritis 3.28 3.55 2.73
Prescription Drugs 3.48 3.74 2.57
Cigarette Smoking 5.94 6.16 2.50
Aspirin 3.07 3.35 2.47
IUDs 4.34 4.58 2.15
Food Additives 4.13 4.36 1.99
NOTE: Entries in the first two columns are mean values for perceived
risk. Respondents classified as "concerned" mentioned addiction,
dependency, abuse or overuse in either the imagery question or the
question about the most serious side-effects of prescription drugs.
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FIGURE CAPTIONS
Figure 1. Risk today versus 20 years ago.
Figure 2. Reactions to a drug crisis scenario: Modification of
opinion in view of additional evidence. Two response
categories -- "take the drug off the market" and
"not sure" -- are not shown in the figure.
Figure 3. Attitudes and opinions regarding warning information.
Figure 4. Perceived risk.
Figure 5. Perceived benefit.
Figure 6. Perceived risk and perceived benefit.
RISK TODAY VERSUS 20 YEARS AGO
Chemicals
Cancer
Heart Disease
Food
Drinking Water
Travel
Climate Changes
Energy Sources
Infec. Diseases
Prescrip. Drugs
j^^^^j^^^^.^^^£^y
0% 25% 50% 75%
Risk today is:
More [k|||j Less lllll Same lilMiil Unsure
100%
REACTIONS TO A DRUG CRISIS SCENARIO
Modification of Opinion
in View of Additional Evidence
rewcr suit: ciietia ^HHBHSHBi
than other drugs WsaSe&m
Risk limited to
specific
patient groups
! ! 1
/ |
More effective e^hhmi
than other drugs HR^^H
Personal positive HBBH^HHHI
experience j^98|^^^H
Good track record ^|HB|
in other countries ^I^HHI
Active info collec
ting by gov't & mfr •I ilBiiii
i ;
0 % 20% 40% 60% 8C)%
I^B leave •mSd- leave- but warn
.
t
-
_
)
Information describing the precautions
and side effects/unwanted effects
associated with taking prescription drugs..
Would help me to
recognize & avoid
problems when
taking the drug.
Would encourage me to
take the drug exactly
as prescribed.
•rvtfxrw wvyvv1]
Ought to describe all
possible side effects
even if some are
extremely unlikely.
Indicates the drug may be
too dangerous to use.
Would make me uneasy
about taking the drug.
Is generally hard
to understand.
Ought to include only
the most likely
side effects.
strongly agree
agree
disagree
strongly disagree
no opinion
0%
*? V ^ W * A
m*- -a^*
^Jfflftri'6 L-vjiSi. A
J
*uaumJ_
25% 50% 75% 100%
Cigarette Smoking
Pesticides
Nuclear Power
Alcohol
Sleeping Pills
Tranquilizers
Antidepressants
Heart Surgery
IUDs
Cancer Drugs
AIDS Drugs
Birth Control Pills
Food Additives
Automobiles
Cleansers
Menopause Drugs
Nonprescription Drugs
X-rays
Antihypertensives
Airplane Travel
Art. sweeteners
Biotech Drugs
Prescription Drugs
Antibiotics
Antiarthritics r-
Laxatives \-
Insulin
Aspirin
Appendectomy
Acupuncture
Vaccines
Herbal Medicines
Vitamin Pills
PERCEIVED RISK
degree of risk
PERCEIVEDBENEFIT
Automobiles1-/
HeartSurgery-1 Insulin-
1 AirplaneTravel-
1 Antibiotics-i
Vaccines-f PrescriptionDrugs-r
CancerDrugs-1
X-rays•
s
AIDSDrugs•1
Antihypertensives
1 Appendectomy
1 Antiarthritics./
BirthControlPillsJ
MenopauseDrugsi Aspirin
j
VitaminPillsi
BiotechDrugs
—
1
Antidepressants
—
i
Cleansers
—
f NonprescriptionDrugs—/
HerbalMedicines
_
f Tranquilizers—j
IUDs
—
i
Acupuncture-l
Laxatives
—
f NuclearPower—1
Pesticides
—
/
SleepingPillsj*
Art.sweetenersr
FoodAdditives/
Alcoho1-J8
CigaretteSmokinc
»F
*T
7 i
4
degreeofbenefit
I.
Cigarette Smoking
Pesticides
Nuclear Power
Alcohol
Sleeping Pills
Tranquilizers
Antidepressants
Heart Surgery
IUDs
Cancer Drugs
AIDS Drugs
Birth Control Pills
Food Additives
Automobiles
Cleansers
Menopause Drugs
Nonprescription Drugs
X-rays
Antihypertensives
Airplane Travel
Art. sweeteners
Biotech Drugs
Prescription Drugs
Antibiotics
Antiarthritics
Laxatives
Insulin
Aspirin
Appendectomy
Acupuncture
Vaccines
Herbal Medicines
Vitamin Pills
RISK AND BENEFIT
t>
- i>
RISK
t>
degree of risk/benefit
_ _~---B>
.-_---&•
=s> BENEFIT
